Blessing M Fubara
Examiner (ID: 2724, Phone: (571)272-0594 , Office: P/1613 )
Most Active Art Unit | 1613 |
Art Unit(s) | 1613, 1618, 1615 |
Total Applications | 2265 |
Issued Applications | 1176 |
Pending Applications | 331 |
Abandoned Applications | 758 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17038243
[patent_doc_number] => 20210255202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => METHODS AND DOSING REGIMENS FOR PREVENTING OR DELAYING ONSET OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA AND MILD CONGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 16/973586
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973586 | METHODS AND DOSING REGIMENS FOR PREVENTING OR DELAYING ONSET OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA AND MILD CONGNITIVE IMPAIRMENT | Jun 11, 2019 | Pending |
Array
(
[id] => 17633808
[patent_doc_number] => 11344512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Titration of tapentadol
[patent_app_type] => utility
[patent_app_number] => 16/439135
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15685
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439135 | Titration of tapentadol | Jun 11, 2019 | Issued |
Array
(
[id] => 16868421
[patent_doc_number] => 20210161888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => COMPOSITION AND METHOD OF TREATING CANCER ASSOCIATED WITH EGFR MUTATION
[patent_app_type] => utility
[patent_app_number] => 17/059694
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059694 | COMPOSITION AND METHOD OF TREATING CANCER ASSOCIATED WITH EGFR MUTATION | May 29, 2019 | Pending |
Array
(
[id] => 16930786
[patent_doc_number] => 20210196675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => USE OF GINKGO BILOBA TERPENE LACTONE IN PREPARATION OF DRUGS FOR PREVENTION AND/OR TREATMENT OF TREMORS AND HEALTHCARE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/056831
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056831 | USE OF GINKGO BILOBA TERPENE LACTONE IN PREPARATION OF DRUGS FOR PREVENTION AND/OR TREATMENT OF TREMORS AND HEALTHCARE PRODUCTS | May 23, 2019 | Pending |
Array
(
[id] => 15175181
[patent_doc_number] => 20190358182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => NOVEL MECHANISM FOR DECREASING OPIOID REWARD
[patent_app_type] => utility
[patent_app_number] => 16/420972
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420972 | NOVEL MECHANISM FOR DECREASING OPIOID REWARD | May 22, 2019 | Abandoned |
Array
(
[id] => 16760998
[patent_doc_number] => 20210106579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => AMELIORATION OF COGNITIVE AND MOTOR DEFICITS ASSOCIATED WITH ALZHEIMER'S
[patent_app_type] => utility
[patent_app_number] => 17/055545
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055545 | AMELIORATION OF COGNITIVE AND MOTOR DEFICITS ASSOCIATED WITH ALZHEIMER'S | May 16, 2019 | Pending |
Array
(
[id] => 16915751
[patent_doc_number] => 20210188843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/054614
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054614 | QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS | May 12, 2019 | Pending |
Array
(
[id] => 14743801
[patent_doc_number] => 20190255074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/400969
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400969 | COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF VISUAL IMPAIRMENTS COMPRISING URSODEOXYCHOLIC ACID | Apr 30, 2019 | Abandoned |
Array
(
[id] => 16837830
[patent_doc_number] => 20210145842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => NEW THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 17/048361
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048361 | NEW THERAPEUTIC USES | Apr 16, 2019 | Pending |
Array
(
[id] => 17005288
[patent_doc_number] => 20210236449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => USE OF CHLOROGENIC ACID IN PREPARING DRUG FOR PREVENTING OR BLOCKING BRAIN AND/OR BONE METASTASES OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 15/733748
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733748 | USE OF CHLOROGENIC ACID IN PREPARING DRUG FOR PREVENTING OR BLOCKING BRAIN AND/OR BONE METASTASES OF LUNG CANCER | Apr 14, 2019 | Pending |
Array
(
[id] => 15083359
[patent_doc_number] => 20190336490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING REMYELINATION
[patent_app_type] => utility
[patent_app_number] => 16/376764
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376764 | COMPOSITIONS AND METHODS FOR INCREASING REMYELINATION | Apr 4, 2019 | Abandoned |
Array
(
[id] => 16655947
[patent_doc_number] => 20210052583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => NOVEL COMBINATIONS OF A TUBULIN POLYMERIZATION INHIBITOR AND A POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR FOR USE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/981232
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981232 | Combinations of a tubulin polymerization inhibitor and a poly (ADP-ribose) polymerase (PARP) inhibitor for use in the treatment of cancer | Apr 3, 2019 | Issued |
Array
(
[id] => 18994533
[patent_doc_number] => 11911349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Rapidly improving vascular conditions by administering vitamin K
[patent_app_type] => utility
[patent_app_number] => 16/372173
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 38
[patent_no_of_words] => 13653
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372173 | Rapidly improving vascular conditions by administering vitamin K | Mar 31, 2019 | Issued |
Array
(
[id] => 16807759
[patent_doc_number] => 20210130312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => INHIBITORS OF EYA3-PROTEIN TYROSINE PHOSPHATASE IN DNA DAMAGE REPAIR SIGNALING OF PULMONARY ARTERIAL HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/044714
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044714 | INHIBITORS OF EYA3-PROTEIN TYROSINE PHOSPHATASE IN DNA DAMAGE REPAIR SIGNALING OF PULMONARY ARTERIAL HYPERTENSION | Mar 28, 2019 | Abandoned |
Array
(
[id] => 17539845
[patent_doc_number] => 11304949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Treatment of hidradenitis suppurativa using JAK inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/370436
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15523
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370436 | Treatment of hidradenitis suppurativa using JAK inhibitors | Mar 28, 2019 | Issued |
Array
(
[id] => 14926205
[patent_doc_number] => 20190298740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING HALLUCINATIONS AND CONDITIONS RELATED TO THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/363173
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363173 | METHODS AND COMPOSITIONS FOR TREATING HALLUCINATIONS AND CONDITIONS RELATED TO THE SAME | Mar 24, 2019 | Abandoned |
Array
(
[id] => 14926115
[patent_doc_number] => 20190298695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => COMPOSITION AND METHOD FOR TREATMENT OF DISEASES ASSOCIATED WITH CENTRAL NERVOUS SYSTEM INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/363977
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363977 | Composition and method for treatment of diseases associated with central nervous system inflammation | Mar 24, 2019 | Issued |
Array
(
[id] => 17554897
[patent_doc_number] => 11311554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Pharmaceutical compositions of testosterone
[patent_app_type] => utility
[patent_app_number] => 16/363376
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5368
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363376 | Pharmaceutical compositions of testosterone | Mar 24, 2019 | Issued |
Array
(
[id] => 14578321
[patent_doc_number] => 20190216769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Topical Application of Delphinidin Compounds Treats Rosacea
[patent_app_type] => utility
[patent_app_number] => 16/358798
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358798 | Topical Application of Delphinidin Compounds Treats Rosacea | Mar 19, 2019 | Abandoned |
Array
(
[id] => 16582803
[patent_doc_number] => 20210017205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Fluoro-Pyridinone Phosphates And Boronates Useful As Antibacterial Agents
[patent_app_type] => utility
[patent_app_number] => 16/980616
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980616 | Fluoro-pyridinone phosphates and boronates useful as antibacterial agents | Mar 13, 2019 | Issued |